Great start! Cash flow positive company, no need for further CR unless for acquisition, market just waking up IMO. Lot less worth a lot more out there. Most not producing revenue just hype.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025